Fig. 4 | Scientific Reports

Fig. 4

From: Real-world data of CanAssist Breast- first immunohistochemistry and AI-based prognostic test

Fig. 4The alt text for this image may have been generated using AI.

Usefulness of CAB in Multifocal/Multicentric tumors. (a) Flow chart representation of recommended protocol to evaluate the intertumoral prognostication in multifocal/multicentric tumors by CAB. Tumor 1 represents clinically high-risk tumor; Tumor 2 represents clinically low risk tumor. (b) Re-stratification of CAB low risk category when second CAB was performed on Tumor 2.

Back to article page